1. Agresti, A. and Bianchi, M.E. (2003): HMGB proteins and gene expression. Curr. Opin. Genet. Dev., 13, 170-178.
2. Berquin, I.M., Min, Y., Wu, R., Wu, H. and Chen, Y.Q. (2005): Expression signature of the mouse prostate. J. Biol. Chem., 280, 36442-36451.
3. Bianchi, M.E. and Agresti, A. (2005): HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev., 15, 496-506.
4. Bosland, M.C. and Prinsen, M.K. (1990): Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2′-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res., 50, 691-699.
5. Cha, J.Y., Wee, J., Jung, J., Jang, Y., Lee, B., Hong, G.S., Chang, B.C., Choi, Y.L., Shin, Y.K., Min, H.Y., Lee, H.Y., Na, T.Y., Lee, M.O. and Oh, U. (2015): Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia. Proc. Natl. Acad. Sci. USA, 112, 9722-9727.